DIRS.INFO The most relevant business & tech news

Indeed, studies show that drinking alcohol is less in vogue with younger millennials and Gen Z. Mounting concern around weight loss drugs GLP-1 drugs, which mimic the action of the glucagon-like peptide-1 hormone and stimulate insulin secretion after a meal, lower blood sugar and send feeling of fullness to the brain. What's more, GLP-1 drugs are an overwhelmingly American topic, with most Europeans unaware of them or unwilling to pay high prices. In total, GLP-1 users are only a very small slice of total alcohol consumers, said Spiros Malandrakis, lead alcohol industry researcher at Euromonitor International. The most vulnerable purveyors are those that are trailing the shift in consumption, notably domestic, non-premium beer brands.

Persons: Katie Pell, Pell, wasn't, millennials, Eli Lilly's Mounjaro, Goldman Sachs, Jason English, Nadine Sarwat, Bernstein, Sarwat, Spiros Malandrakis, —, BUD YTD, who'd, Mickey Velado, Brian Sudano, Nell Healy, Healy, she's, Malandrakis, Ryan Brigden, Brigden, Sudano, Joseph Gabelli, Gabelli, Z, there's, it's, Garrett Nelson, They've, seltzer, Nelson, Molson Coors, Bud, he's Organizations: Gallup, Drugs, Nordisk's Ozempic, JPMorgan, CNBC, Euromonitor, Anheuser, Busch Inbev, Beverage Marketing, Constellation, Guinness, Corona, Heineken, Athletic Brewing Company, Heineken Holding, Carlsberg, Constellation Brands, Malandrakis, Beverage, Gabelli, Diageo, Molson Coors, Busch InBev, Molson, Anheuser Busch Locations: Brooklyn, U.S, GLP, imbibing, Angeles, Colorado, Washington, California, North Carolina, San Francisco Bay, Europe, British, Brazil, India

☆ This Johnson & Johnson spin-off could rally more than 20%, Goldman Sachs predicts
▼ + stars: | 2023-08-24 | by ( Alex Harring | ) www.cnbc.com time to read: +1 min

Investors may want to scoop up newly public company Kenvue on the cheap, Goldman Sachs said. Analyst Jason English upgraded the stock to buy from neutral. "We see compelling relative valuation with an approaching catalyst for a re-rating," English said in a note to clients Wednesday. KVUE .SPX ALL mountain Kenvue vs. the S & P 500 Kenvue, the Johnson & Johnson spin-off sporting brands such as Neutrogena and Tylenol that went public earlier this year, has fallen about 14% from its mid-May peak. In that period, the stock has trailed the S & P 500 by more than 20 percentage points.

Persons: Goldman Sachs, Jason English, Johnson, FactSet, — CNBC's Michael Bloom Organizations: Currency Locations: Wednesday's, KVUE

☆ Goldman sees big gains in this food stock even as industry growth becomes scarce
▼ + stars: | 2023-06-27 | by ( Brian Evans | ) www.cnbc.com time to read: +1 min

Kellogg will shine in an increasingly tough environment for the food industry, according to Goldman Sachs. The bank upgraded Kellogg to buy and raised its price target to $83 from $78. English also noted that Kellogg is woefully undervalued compared with the growth opportunity the stock presents investors, despite concerns over the company's planned split. Kellogg stock has slumped nearly 8% from the start of the year. K YTD mountain Kellogg stock has pulled back more than 7% in 2023.

Persons: Kellogg, Goldman Sachs, Jason English, — CNBC's Michael Bloom Organizations: Kellogg Locations: Monday's

☆ Now is the time to buy Nomad Foods, Goldman says, highlighting near-term catalysts
▼ + stars: | 2023-02-27 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

Nomad's management recently delivered a below-consensus earnings outlook — which, according to Goldman Sachs, paradoxically, also presents a promising investment opportunity. Analyst Jason English upgraded Nomad shares to buy from neutral, saying the frozen food parent of Birds Eye (in Europe) and Findus, is currently at a favorable investment point. "With potential upward revisions on horizon, we see NOMD's near-trough valuation levels, both in context of its history and relative to broader Food peers as an attractive investment opportunity with favorable risk-reward ahead," English continued. Furthermore, Goldman believes that Nomad's current valuation is attractive relative to its historic levels, and its peers. English maintained his price target of $21, which implies 21% upside from Friday's closing price.

☆ Can't figure out this economy? Walmart, Home Depot are having trouble, too
▼ + stars: | 2023-02-26 | by ( Tim Mullaney | ) www.cnbc.com time to read: +7 min

Joe Raedle | Getty Images News | Getty ImagesIf you think the economy is confusing right now, consider how baffling it must look to Home Depot and Walmart. Home Depot said consumer spending is holding up, but that it expects a flat sales-growth year overall, with declining profits. Friday's PCE showed consumer spending rose more than expected as prices increased, jumping 1.8% for the month compared to the estimate of 1.4%. It wasn't a good week for the retail sector or consumer stocks, either. "The outlook for sustained consumer spending growth remains," wrote consumer analyst Jason English.

☆ A simple options strategy has been a big winner this earnings season, Goldman says
▼ + stars: | 2023-01-27 | by ( Jesse Pound | ) www.cnbc.com time to read: +2 min

An earnings season that has been better-than-feared and a relatively calm stock market has led to big gains for a simple options strategy, according to Goldman Sachs. Vishal Vivek of Goldman's derivatives research team said in a note to clients on Wednesday that the implied volatility for stocks around earnings has been falling in recent weeks, making a simple strategy of buying call options a winner. "Buying calls ahead of earnings for the average U.S. stock with liquid options has yielded +29% return on premium," so far this quarter, the note said. Two stocks with upcoming earnings reports that could be good candidates for this strategy are breakfast cereal maker Post Holdings and agribusiness company Bunge , Goldman said. Post will report earnings after the bell on Feb. 2, while Bunge will announce on the morning of Feb. 8.

☆ Six stocks Goldman Sachs likes ahead of earnings
▼ + stars: | 2023-01-21 | by ( Alex Harring | ) www.cnbc.com time to read: +7 min

Goldman Sachs' analysts have stocks they are confident about going into a new earnings season. The stocks we found are Amazon , ServiceNow , Colgate-Palmolive , Boeing , Microsoft and Cleveland-Cliffs . Colgate-Palmolive Analyst Jason English raised estimates ahead of Colgate-Palmolive's Jan. 27 earnings as headwinds from foreign exchange turn in to tailwinds. While English said the uncertain global environment could hurt Colgate's business, he still expects the toothpaste and soap maker to meet Goldman's 9% per-share earnings growth forecast for the year. Specifically, we are now forecasting AWS growth to decelerate to +21% YoY (vs. +27.5% YoY in Q3'22) with more subdued growth expectations in 2023.

☆ Earnings playbook: How to trade a big week of results including Netflix and Goldman Sachs
▼ + stars: | 2022-10-16 | by ( Fred Imbert | ) www.cnbc.com time to read: +13 min

Tuesday Johnson & Johnson is set to report earnings in the premarket, followed by a call at 8:30 a.m. What history shows: FactSet data shows Johnson & Johnson has beaten earnings expectations every quarter since 2011. Goldman Sachs is set to report earnings before the market open. Netflix is set to report earnings after the bell, followed by a conference call between management and analysts at 6 p.m. What history shows: American Airlines has beaten earnings expectations 89% of the time over its history, according to Bespoke.

☆ It's too early to buy the dip, investor says, naming 8 stocks to buy when the time is right
▼ + stars: | 2022-10-12 | by ( Ganesh Rao | ) www.cnbc.com time to read: +3 min

Excluding the energy sector, earnings estimates for the third quarter are already down 2.6% compared to the previous three months, according to Refinitiv. With high inflation and rising interest rates, Ricciardi says stock market valuations will need to fall further before buyers return. Ricciardi said investors should reposition toward stocks sensitive to interest rates – the so-called defensive stocks – and identified companies in the consumer staples sector. Procter & Gamble , Coca Cola and Pepsi Co were among the stocks he thinks might fair well while interest rates continue to increase. Andrew Bischof from Morningstar's equity research team was the sole analyst with a sell rating on both NextEra and Duke Energy.

☆ Goldman upgrades Estee Lauder, says investors are underappreciating path to 'robust' sales growth
▼ + stars: | 2022-09-21 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

It's time to load up on Estee Lauder shares, according to Goldman Sachs. Analyst Jason English upgraded the cosmetic company to buy from neutral, saying it is a stronger company emerging from the pandemic with a "pathway for robust sales growth acceleration." Estee Lauder shares rose more than 1% in the premarket. English said Estee Lauder shares have been depressed by concern over China's zero-Covid policy. English also sees a rebound in China sales, noting that sales in the country can sustain 15% growth beyond 2023.

Search resuls for: "Jason English"

10 mentions found